Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates stable financial health with strategic debt refinancing, positive market trends, and optimistic guidance. The Q&A section supports this with strong growth expectations and effective handling of strike events. Despite some unclear responses, the overall sentiment is positive due to potential margin growth, healthy business pipeline, and strategic market positioning.
Full Year 2025 Revenue $2.73 billion, a year-over-year decrease of 8%. The decline was attributed to a decrease in demand across various segments.
Full Year 2025 Adjusted EBITDA $234 million, a decrease of 31% year-over-year. This was due to lower revenue and a decline in gross margin.
Debt Reduction in 2025 $285 million. This reduction was part of the company's efforts to improve its financial position.
Fourth Quarter 2025 Revenue $748 million, 2% higher than the year-ago quarter and $18 million above the high end of guidance. The increase was driven by labor disruption revenue.
Labor Disruption Revenue in Q4 2025 $124 million, nearly doubled compared to the year-ago quarter. This was due to two large labor disruption events.
Nurse and Allied Revenue in Q4 2025 $491 million, an 8% year-over-year increase. Excluding labor disruption, the segment revenue was down 7% year-over-year, but improved from a 13% decline in the third quarter.
Physician and Leadership Solutions Revenue in Q4 2025 $170 million, down 2% year-over-year. The decline was attributed to seasonality and disruptions in demand.
Technology and Workforce Solutions Revenue in Q4 2025 $88 million, down 18% year-over-year or 14% excluding the divested Smart Square business. The decline was due to adverse revenue mix and lower margins in Language Services.
Gross Margin for Q4 2025 26.1%, a decline of 370 basis points year-over-year. The reduction was influenced by labor disruption revenue, which reduced gross margin by 130 basis points.
Adjusted EBITDA for Q4 2025 $54 million, down 27% year-over-year. The decline was due to lower gross margins and increased SG&A expenses.
Net Loss for Q4 2025 $8 million, compared to a net loss of $188 million in the prior year period. The prior year's loss included a non-cash goodwill impairment charge.
Adjusted Earnings Per Share for Q4 2025 $0.22, compared to $0.75 in the prior year period. The decline was due to lower adjusted EBITDA.
Operating Cash Flow for Q4 2025 $76 million. This was supported by a reduction in days sales outstanding.
Full Year 2025 Gross Margin 28.3%, a decrease of 250 basis points from the prior year. The decline was due to adverse revenue mix and lower margins in certain segments.
Full Year 2025 Adjusted Earnings Per Share $1.36, compared to $3.31 in the prior year. The decline was due to lower adjusted EBITDA and gross margins.
Language Services Expansion: Investing in AI technology to support administrative and nonclinical interactions with patients, expanding capabilities to support broader client choices.
VMS Enhancements: Deployed advanced analytics, generative AI, and expanded support for internal float pool and agency management.
Labor Disruption Revenue: Generated $124 million in Q4 2025, nearly double the previous year, with $600 million expected in Q1 2026 from multiple strike events.
Market Share Gains: Positioned to gain share in direct and vendor-neutral segments, leveraging AI-enabled recruiting and workforce management solutions.
Debt Reduction: Reduced debt by $285 million in 2025.
Operational Efficiency: Automated and tech-enabled business processes to handle higher demand, improving speed to fill and onboarding capabilities.
Strategic Partnerships: Focused on building long-term partnerships with clients for workforce management and labor disruption support.
Growth Transition: 2026 identified as a transition year to return all businesses to growth, targeting sustainable organic revenue growth of 4%-6% annually post-2026.
Labor Disruption Events: The company is experiencing significant labor disruption events, which, while driving revenue, are reducing consolidated gross margins and increasing operational costs. These events require additional resources and create operational challenges.
Decline in Technology and Workforce Solutions Revenue: Revenue in this segment decreased by 18% year-over-year, with specific declines in Language Services and VMS revenue. This decline is attributed to adverse revenue mix shifts, lower margins, and the sale of Smart Square.
Physician and Leadership Solutions Revenue Decline: Revenue in this segment decreased by 2% year-over-year, with locum tenens and interim leadership showing declines. Seasonal demand declines and client disruptions due to strike events are contributing factors.
Increased SG&A Expenses: Sequential increases in SG&A expenses are driven by unfavorable professional liability actuarial adjustments, increased bad debt expenses, and additional costs to support labor disruption events.
Gross Margin Decline: Consolidated gross margin declined by 370 basis points year-over-year, impacted by lower labor disruption margins and adverse revenue mix shifts.
Economic and Market Pressures: The healthcare labor market is showing signs of normalization, but clients are increasingly seeking cost-effective solutions, which may pressure pricing and margins.
Dependence on Labor Disruption Revenue: A significant portion of revenue is derived from labor disruption events, which are unpredictable and may not be sustainable long-term.
Nurse and Allied Revenue: Expected to increase by more than 135% year-over-year in Q1 2026, or 2% to 4% year-over-year excluding labor disruption, and 4% to 6% sequentially from Q4 2025.
Physician and Leadership Revenue: Projected to decline by 5% to 8% year-over-year in Q1 2026, with interim leadership down mid-single digits, search flat to up, and locums down mid-single digits year-over-year. Sequential growth expected in the middle quarters of 2026.
Technology and Workforce Solutions Revenue: Anticipated to decline in the mid- to upper teens year-over-year in Q1 2026, or low teens excluding Smart Square. Language Services revenue expected to be modestly lower sequentially.
Labor Disruption Revenue: Assumed to be $600 million in Q1 2026 from multiple strike events, reducing consolidated gross margin but driving operating leverage.
Language Services: Expected to see gross margin benefits in the second half of 2026 from a tiered service strategy addressing price competition. Anticipated return to year-over-year revenue growth later in 2026.
Consolidated Revenue Growth Post-2026: Excluding labor disruption, sustainable organic revenue growth of 4% to 6% per year is projected, with operating expenses growing at half the rate of revenue growth, leading to 10% to 15% adjusted EBITDA growth.
Market Trends and Strategic Positioning: Healthcare labor market conditions are normalizing in 2026, with clients increasingly adopting blended labor models and centralizing contingent labor spend. AMN is positioned to support these trends and gain market share.
The selected topic was not discussed during the call.
The earnings call summary indicates stable financial health with strategic debt refinancing, positive market trends, and optimistic guidance. The Q&A section supports this with strong growth expectations and effective handling of strike events. Despite some unclear responses, the overall sentiment is positive due to potential margin growth, healthy business pipeline, and strategic market positioning.
The earnings call summary and Q&A indicate a stable competitive market, growing demand for contingent labor, and positive business trends, such as increased MSP revenue and international nurse staffing growth. While management avoided specific guidance, the overall sentiment is positive with expected bill rate stabilization and strategic investments in technology. Given the company's market cap and the positive outlook, a 2% to 8% stock price increase is likely over the next two weeks.
The earnings call summary indicates a mixed performance: strong Q1 revenue but weak Q2 guidance with a projected revenue decline and negative operating margins. Additionally, a net loss due to impairment charges and legislative uncertainties affecting demand are concerning. The Q&A reveals stable demand but no clear growth catalysts, with management avoiding specifics on key issues like retrogression. Despite some positive signs (e.g., new partnerships), the overall sentiment is negative, particularly given the market cap, as smaller companies tend to react more strongly to such mixed signals.
The earnings call reveals a decline in financial performance across multiple revenue streams, with significant year-over-year drops and a net loss. Although there are some competitive wins in VMS and MSP and growth in language services, these are characterized as small to medium. The Q&A highlights competitive pressures and management's reluctance to provide specific guidance, which could increase uncertainty. The market cap suggests moderate sensitivity, leading to a prediction of a negative stock price movement in the range of -2% to -8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.